ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

OPTI Optibiotix Health Plc

19.60
-1.40 (-6.67%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Optibiotix Health Plc LSE:OPTI London Ordinary Share GB00BP0RTP38 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.40 -6.67% 19.60 20.00 20.50 21.50 20.25 21.00 572,429 16:35:01
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Noncomml Resh Organizations 457k 2.59M 0.0284 7.13 18.47M
Optibiotix Health Plc is listed in the Noncomml Resh Organizations sector of the London Stock Exchange with ticker OPTI. The last closing price for Optibiotix Health was 21p. Over the last year, Optibiotix Health shares have traded in a share price range of 5.75p to 43.50p.

Optibiotix Health currently has 91,190,661 shares in issue. The market capitalisation of Optibiotix Health is £18.47 million. Optibiotix Health has a price to earnings ratio (PE ratio) of 7.13.

Optibiotix Health Share Discussion Threads

Showing 35476 to 35496 of 147425 messages
Chat Pages: Latest  1421  1420  1419  1418  1417  1416  1415  1414  1413  1412  1411  1410  Older
DateSubjectAuthorDiscuss
22/3/2018
11:38
Great ramp.. Will it help.. No.. Just like all the other mega ramps.
monkeywench1
22/3/2018
11:37
Excellent response from SoH, if investors can't see the scale of the opportunity here and how close we are to a tipping point (when the herd catch on) then IMHO they should stick to FTSE100 stocks. I'll continue to add on weakness. Some opportunity's are just to good to pass up on
trotterstrading
22/3/2018
11:33
Great post Primal.
mouse20
22/3/2018
10:58
People are over reacting here when there is nothing wrong. I wrote to SOH, his response:"The current share price fluctuations are part of a trend we have seen a few times over the last 12 months where market makers and some traders selectively pick out a couple of areas to panic/concern investors to put download pressure on the price. History tells us that the price typically bounces back as the fundamentals on which the business has been built have not changes. These are:- 1. We are leading the field in the microbiome space, a market growing at 22.3% per year, and described by health experts as 'healthcare's most promising and lucrative frontier'. Our recent corporate visits to the US and across Europe added further reassurance to our belief that we have world leading technology which is exciting the interest of major corporates.2. The company has been built on four platforms: SkinBiotherapeutics (of which OptiBiotix owns 42%), OptiBiome (of which SlimBiome is one product), Optiscreen (where we have launched LP-LDL) and OptIBiotics (which includes our microbiome modulators). These diversify investor risk and create multiple opportunities across major markets. We believe we are unique in capturing such a wide breadth of opportunities in the microbiome space.3. In the last 3 years we have created new science, tested it in the laboratory, and then performed clinical studies, so we can be assured we have safe and effective products. Our products have won international awards and we have won awards for best science at major scientific events in both 2017 and 2018. This demonstrates the leading nature of both our science and products. We now have world leading key opinion leaders presenting our science for us which creates corporate interest. This is all part of building a strong and valuable business. 4. Our strategy has been clearly defined from the beginning: develop the science, strike joint development deals with global partners, prove the science in humans studies, and then strike deals with manufacturers, formulators, and distributors to commercialise the products. This is a track I have gone down many times and builds true value. 5. We have struck deals with major corporate partners such as Tata (x2) and DSM (the worlds largest ingredient supplier) to either manufacture product on a global scale or develop applications for themselves consistnet with our JV and JDA strategy. We are bound by confidentiality not to disclose the launch plans of these companies as we are the 'intel inside' and not the product owner.6. We are rapidly transitioning from a product development company to the commercial stage of the companies development. This started in Europe in May 2017 and USA in late September. Since then we have been developing a rich deal pipeline which we believe will build into significant revenues over time. We would hope to see each divisions building revenues of between £5-£10m in the forthcoming years giving valuations for each division of £50 to £100m. Most investors will have seen from the recent RNS's the gradual evolution from small privately owned pharma companies to larger >£100m revenue companies like Cereal Ingredients and Gallenicum. We will continue on this path as it reduces the dependency on one or two big deals but has to be negotiated carefully so as not to exclude the global opportunity.7. Given we are in a new space with new partners we believe providing revenue forecasts is high risk until we have completed our commercial transition. However, we have often provided guidance on likely deal contributions.8. Typical commercial deals should generate annual revenue in the £250,000 - £500,000 range for smaller privately owned companies with deals with companies with >£100m revenues typically worth £750k-£1.25m pa. We would also anticipate larger deals in the multi-million range with global corporates and large retailers.9. On AIM their is often a disconnect between the scale of opportunity and the share price which can often be artificially manipulated (higher or lower) with a number of trades. However, as outlined in my proactive interview investors should be able to see that we are building commercial momentum across all our platforms, starting with the smaller deals with pharma groups which are quicker to execute and building into larger deals with the likes of Cereal Ingredients, Gallenicum, and Fine Foods. We anticipate this trend will continue interspersed with a number of corporate and retail deals."
primal123
22/3/2018
10:12
IG and yesterday: I 'had' a small holding there (25k) and they were stopped out yesterday.

Am I sorry - yes and no: glad to have this particular misery removed from my life, and will move back in when we really have turned the corner i.e. a demonstration of prospects of real significant income.

Will I have to pay more? We shall see how low this goes. If I had got out when 80 and 70 weren't holding, then probably not. A lesson there for me that's for sure.

Good luck all, and I genuinely mean that, am now concentrating on other stocks I hold.

Best wishes - Mike

spike_1
22/3/2018
09:39
I phoned them up yesterday. Just general comments from the staff I spoke to.
pj 1
22/3/2018
09:39
I have a open short to take me to my core holding entry @ 53p. I explained my logic to a friend and that friend explained it to Soh. I know the dangers and accept those dangers. I don't expect to have my position open for very long, days in fact by the looks of the price action.
incanus
22/3/2018
09:31
PJ can i ask how you would know in ref to the following. 'IG and Spreadex hadn't noticed any significant trades as of yesterday.'
pglancy
22/3/2018
09:26
What shorts?
m4rtinu
22/3/2018
09:17
Fully loaded, but drop to 50p will see me raiding the boys piggy bank
zebbo
22/3/2018
08:59
The shorts have to close at some point and we know for a fact there's a few of those open!

For me it could have made a few points but the risk reward for me on shorting this is crazy.

Soh could surprise any day.

S

shrewdmole
22/3/2018
08:58
Lounge do touch need your bucket of tears emptied?
monkeywench1
22/3/2018
08:46
ramas
22 Mar '18 - 08:38 - 33451 of 33451
0 0 0
Feels like forward selling=
====================================================================================
Unsure ramas. IG and Spreadex hadn't noticed any significant trades as of yesterday. There are other providers though off course

Pi's always fear price action pre Results, sometimes its an indicator, sometimes not. That support needs to hold.

pj 1
22/3/2018
08:43
Bulls still can't see it.They will.soon..
vanduke
22/3/2018
08:38
Feels like forward selling
ramas
22/3/2018
08:35
Good ole Shrewdie,trouble is what happens to the share price when all these on this thread cannot "top up" anymore,'cause we don't seem to be getting any or very few new buyers.
scotty1
22/3/2018
08:32
The ramping has clearly been orchestrated. Unfortunately the Rampers are ineffectual... The market dictates the share price
monkeywench1
22/3/2018
08:29
Final capitulation?
malreid
22/3/2018
08:21
Done my bit!!
shrewdmole
22/3/2018
08:17
Yep, clearly orchestrated IMO. As I said yest.. where are the TR1's? There ain't none, and won't be none either
trotterstrading
22/3/2018
08:14
Looks like another stormingly good day on the cards
Persistent seller no buyers no news
Perfectly bad storm!!! :(

judijudi
Chat Pages: Latest  1421  1420  1419  1418  1417  1416  1415  1414  1413  1412  1411  1410  Older

Your Recent History

Delayed Upgrade Clock